NCB-004
长效生长激素（浙江新码生物医药）
Report date: 2023/03/30 14:21:14
Base Information
Drug NameNCB-004
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZhejiang Xinma Biomedicine Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesZhejiang Xinma Biomedicine Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A